RxDoctor Payments Data

Darryl Kaelin, MD

Physical Medicine & Rehabilitation · Louisville, KYNPI 1922027044

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,775 of the $19,235 with a category attached, or 82.0%. AbbVie accounts for 93.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $9,231 and has fallen 99.1% since, to $87 in 2025. Among physical medicine & rehabilitation clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,235in general payments, 2019–2025

Across 78 payments — averaging $246.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$18K
  • Merz Pharmaceuticals, LLC$802
  • Ipsen Biopharmaceuticals, Inc$341
  • Otsuka America Pharmaceutical, Inc.$51
  • Merz North America, Inc.$12

What the payments were for

  • Consulting fees$5403%
  • Speaking & faculty fees$15,77582%
  • Travel & lodging$9875%
  • Food & beverage$1,93310%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,235 in reported general payments places this provider in the 95th percentile of 104 physical medicine & rehabilitation providers in Kentucky.

See all physical medicine & rehabilitation providers in Kentucky

Medicare billing

Part B allowed, 2024
$88,562
Medicare patients
259
Services billed
1,201

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuedextaDextromethorphan Hbr/Quinidine34$62,215
EliquisApixaban22$11,500
Dantrolene Sodium63$6,939
Baclofen156$2,659
AmantadineAmantadine Hcl91$2,571
Methylphenidate Hcl47$1,506
Gabapentin102$1,462
Atomoxetine Hcl13$1,250
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen45$989
Tramadol Hcl22$918
Tizanidine Hcl69$904
Levetiracetam45$893
Divalproex Sodium39$694
Trazodone Hcl99$676
Pregabalin35$671

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →